DMK Pharmaceuticals (DMK) Total Liabilities

Annual Total Liabilities

$11.74 M
-$676.30 K-5.45%

December 1, 2022


Summary


Performance

DMK Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherDMKbalance sheetmetrics:

Quarterly Total Liabilities

$14.25 M
-$2.32 M-14.01%

September 1, 2023


Summary


Performance

DMK Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherDMKbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

DMK Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.5%+53.4%
3 y3 years-20.9%-13.7%
5 y5 years-1.0%+14.9%

DMK Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.4%at low-24.0%-34.8%
5 y5-year-57.1%at low-47.9%-34.8%
alltimeall time-57.1%-97.4%-47.9%-100.7%

DMK Pharmaceuticals Total Liabilities History

DateAnnualQuarterly
Sep 2023
-
$14.25 M(-14.0%)
Jun 2023
-
$16.57 M(-11.6%)
Mar 2023
-
$18.76 M(+59.8%)
Dec 2022
$11.74 M(-5.4%)
$11.74 M(+26.3%)
Sep 2022
-
$9.29 M(-12.8%)
Jun 2022
-
$10.65 M(-27.3%)
Mar 2022
-
$14.65 M(+18.0%)
Dec 2021
$12.42 M(-54.6%)
$12.42 M(+17.1%)
Sep 2021
-
$10.61 M(-37.7%)
Jun 2021
-
$17.03 M(-33.1%)
Mar 2021
-
$25.46 M(-7.0%)
Dec 2020
$27.37 M(+84.4%)
$27.37 M(+65.7%)
Sep 2020
-
$16.52 M(-0.4%)
Jun 2020
-
$16.58 M(+37.5%)
Mar 2020
-
$12.06 M(-18.7%)
Dec 2019
$14.84 M(+27.2%)
$14.84 M(+18.3%)
Sep 2019
-
$12.54 M(-5.6%)
Jun 2019
-
$13.28 M(+3.1%)
Mar 2019
-
$12.88 M(+10.4%)
Dec 2018
$11.67 M(-1.6%)
$11.67 M(-5.9%)
Sep 2018
-
$12.40 M(-11.1%)
Jun 2018
-
$13.96 M(+35.0%)
Mar 2018
-
$10.33 M(-12.8%)
Dec 2017
$11.86 M(-5.2%)
$11.86 M(+15.4%)
Sep 2017
-
$10.28 M(+1.7%)
Jun 2017
-
$10.11 M(-21.1%)
Mar 2017
-
$12.82 M(+2.5%)
Dec 2016
$12.51 M(+355.1%)
$12.51 M(+4.3%)
Sep 2016
-
$11.99 M(-16.4%)
Jun 2016
-
$14.33 M(+261.8%)
Mar 2016
-
$3.96 M(+44.2%)
Dec 2015
$2.75 M(-19.0%)
$2.75 M(+23.2%)
Sep 2015
-
$2.23 M(+6.3%)
Jun 2015
-
$2.10 M(-7.7%)
Mar 2015
-
$2.28 M(-1.9%)
Dec 2014
$3.39 M(+15.7%)
-
Sep 2014
-
$2.32 M(+21.7%)
Jun 2014
-
$1.91 M(-35.0%)
Mar 2014
$2.93 M(-37.3%)
$2.93 M(-37.1%)
Dec 2013
-
$4.67 M(-44.8%)
Sep 2013
-
$8.46 M(-6.9%)
Jun 2013
-
$9.09 M(+94.2%)
Mar 2013
$4.68 M(+61.7%)
$4.68 M(+12.3%)
Dec 2012
-
$4.16 M(-28.6%)
Sep 2012
-
$5.83 M(-3.5%)
Jun 2012
-
$6.05 M(+109.1%)
Mar 2012
$2.89 M(-7.1%)
$2.89 M(+15.5%)
Dec 2011
-
$2.50 M(+4.7%)
Sep 2011
-
$2.39 M(+25.0%)
Jun 2011
-
$1.91 M(-38.6%)
Mar 2011
$3.11 M(-37.1%)
$3.11 M(-7.3%)
Dec 2010
-
$3.36 M(-33.2%)
Sep 2010
-
$5.03 M(-12.7%)
Jun 2010
-
$5.75 M(+16.3%)
Mar 2010
$4.95 M
$4.95 M(+24.7%)
Dec 2009
-
$3.97 M(+13.9%)
Sep 2009
-
$3.49 M(+21.2%)
DateAnnualQuarterly
Jun 2009
-
$2.88 M(+124.4%)
Mar 2009
-
$1.28 M(+23.9%)
Dec 2008
$1.03 M(+14.4%)
$1.03 M(+10.3%)
Sep 2008
-
$938.00 K(+4.3%)
Jun 2008
-
$899.00 K(+4.9%)
Mar 2008
-
$857.00 K(-5.2%)
Dec 2007
$904.30 K(-16.4%)
$904.30 K(+42.2%)
Sep 2007
-
$636.00 K(+15.2%)
Jun 2007
-
$552.00 K(-30.4%)
Mar 2007
-
$793.00 K(-26.7%)
Dec 2006
$1.08 M(-91.6%)
$1.08 M(-91.5%)
Sep 2006
-
$12.78 M(+8.6%)
Jun 2006
-
$11.77 M(-5.5%)
Mar 2006
-
$12.45 M(-3.7%)
Dec 2005
$12.93 M(-37.3%)
$12.93 M(+17.7%)
Sep 2005
-
$10.98 M(+7.7%)
Jun 2005
-
$10.20 M(-50.4%)
Mar 2005
-
$20.54 M(-0.3%)
Dec 2004
$20.61 M(+21.8%)
$20.61 M(+618.2%)
Sep 2004
-
$2.87 M(-83.1%)
Jun 2004
-
$16.98 M(-2.8%)
Mar 2004
-
$17.47 M(+3.3%)
Dec 2003
$16.91 M(-5.2%)
$16.91 M(+2.1%)
Sep 2003
-
$16.56 M(-2.0%)
Jun 2003
-
$16.89 M(+0.5%)
Mar 2003
-
$16.82 M(-5.8%)
Dec 2002
$17.84 M(+607.4%)
$17.84 M(+775.6%)
Sep 2002
-
$2.04 M(-38.6%)
Jun 2002
-
$3.32 M(+16.3%)
Mar 2002
-
$2.85 M(+13.0%)
Dec 2001
$2.52 M(+2.4%)
$2.52 M(+54.9%)
Sep 2001
-
$1.63 M(+33.1%)
Jun 2001
-
$1.22 M(-55.4%)
Mar 2001
-
$2.75 M(+11.4%)
Dec 2000
$2.46 M(-51.4%)
$2.46 M(-34.4%)
Sep 2000
-
$3.76 M(-15.7%)
Jun 2000
-
$4.46 M(+7.0%)
Mar 2000
-
$4.17 M(-17.9%)
Dec 1999
$5.07 M(-4.3%)
$5.07 M(+1.5%)
Sep 1999
-
$5.00 M(-9.1%)
Jun 1999
-
$5.50 M(+12.2%)
Mar 1999
-
$4.90 M(-7.5%)
Dec 1998
$5.30 M(+307.7%)
$5.30 M(+341.7%)
Sep 1998
-
$1.20 M(+100.0%)
Jun 1998
-
$600.00 K(-14.3%)
Mar 1998
-
$700.00 K(-46.2%)
Dec 1997
$1.30 M(+333.3%)
$1.30 M(+85.7%)
Sep 1997
-
$700.00 K(-800.0%)
Jun 1997
-
-$100.00 K(-150.0%)
Mar 1997
-
$200.00 K(-33.3%)
Dec 1996
$300.00 K(-25.0%)
$300.00 K(+50.0%)
Sep 1996
-
$200.00 K(+100.0%)
Jun 1996
-
$100.00 K(-50.0%)
Mar 1996
-
$200.00 K(-50.0%)
Dec 1995
$400.00 K
$400.00 K(+100.0%)
Sep 1995
-
$200.00 K(-91.7%)
Jun 1995
-
$2.40 M

FAQ

  • What is DMK Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for DMK Pharmaceuticals?
  • What is DMK Pharmaceuticals annual total liabilities year-on-year change?
  • What is DMK Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for DMK Pharmaceuticals?
  • What is DMK Pharmaceuticals quarterly total liabilities year-on-year change?

What is DMK Pharmaceuticals annual total liabilities?

The current annual total liabilities of DMK is $11.74 M

What is the all time high annual total liabilities for DMK Pharmaceuticals?

DMK Pharmaceuticals all-time high annual total liabilities is $27.37 M

What is DMK Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, DMK annual total liabilities has changed by -$676.30 K (-5.45%)

What is DMK Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of DMK is $14.25 M

What is the all time high quarterly total liabilities for DMK Pharmaceuticals?

DMK Pharmaceuticals all-time high quarterly total liabilities is $27.37 M

What is DMK Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, DMK quarterly total liabilities has changed by +$4.96 M (+53.38%)